CELLULAR & MOLECULAR BIOLOGY LETTERS

Scope & Guideline

Connecting Ideas, Inspiring Innovations in Molecular Biology

Introduction

Explore the comprehensive scope of CELLULAR & MOLECULAR BIOLOGY LETTERS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore CELLULAR & MOLECULAR BIOLOGY LETTERS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1425-8153
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationCELL MOL BIOL LETT / Cell. Mol. Biol. Lett.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'CELLULAR & MOLECULAR BIOLOGY LETTERS' is dedicated to advancing the understanding of cellular and molecular biology with a focus on disease mechanisms, therapeutic strategies, and innovative technologies. It encompasses a wide range of topics that reflect the interdisciplinary nature of modern biological research.
  1. Cancer Biology:
    Research on the molecular mechanisms underlying cancer progression, including studies on tumor microenvironments, cancer stem cells, and therapeutic resistance.
  2. Cellular Signaling and Regulation:
    Exploration of signaling pathways involved in cellular processes such as proliferation, differentiation, and apoptosis, with implications for disease treatment.
  3. Genomics and Epigenetics:
    Investigation of genetic and epigenetic factors influencing cell behavior, including studies on non-coding RNAs, methylation patterns, and gene editing technologies.
  4. Metabolic Disorders:
    Research focused on the molecular basis of metabolic diseases, particularly how cellular metabolism affects disease progression and treatment responses.
  5. Stem Cell Biology:
    Studies on the mechanisms of stem cell differentiation, regeneration, and their roles in tissue repair and cancer.
  6. Neurobiology and Neurodegenerative Diseases:
    Investigations into the cellular and molecular underpinnings of neurological disorders, including studies on neuroinflammation and synaptic plasticity.
  7. Innovative Therapeutics:
    Research into novel therapeutic approaches, including the use of stem cells, exosomes, and CRISPR technologies for disease treatment.
The journal has increasingly focused on several emerging themes that reflect the current trends in cellular and molecular biology. This section outlines these trending areas of research, highlighting their significance in advancing scientific knowledge and therapeutic development.
  1. RNA Modifications and Non-coding RNAs:
    A surge in research on RNA modifications, particularly N6-methyladenosine (m6A), and the roles of non-coding RNAs in gene regulation and cancer biology is evident.
  2. Targeted and Precision Medicine:
    Emerging studies emphasize personalized therapeutic approaches, particularly in cancer treatment, through the use of biomarkers and tailored therapies.
  3. Microbiome Influence on Disease:
    Research increasingly explores how the microbiome affects cellular processes and disease outcomes, revealing significant interactions between gut health and systemic diseases.
  4. Autophagy and Cellular Homeostasis:
    There is a growing interest in the role of autophagy in maintaining cellular health and its implications for various diseases, including cancer and neurodegeneration.
  5. CRISPR and Gene Editing Technologies:
    The application of CRISPR and other gene-editing technologies continues to expand, influencing research in genetic diseases, cancer, and therapeutic innovations.
  6. Cancer Immunotherapy:
    Research on the mechanisms of immune evasion by tumors and the development of immunotherapeutic strategies is gaining momentum, reflecting the shift towards harnessing the immune system in cancer treatment.
  7. Metabolic Reprogramming in Disease:
    An increasing focus on how metabolic changes in cells contribute to disease progression, particularly in cancer and metabolic disorders, is becoming a prominent theme.

Declining or Waning

While 'CELLULAR & MOLECULAR BIOLOGY LETTERS' continues to explore a diverse range of topics, certain areas of research have become less prominent in recent publications. This section highlights those themes that are waning in focus.
  1. Traditional Pharmacology:
    Research that emphasizes conventional drug development and pharmacodynamics has seen a decline, with a shift towards more innovative and targeted therapeutic strategies.
  2. Basic Cellular Mechanisms:
    Studies solely focused on fundamental cellular processes without a clear application to disease or therapeutic relevance appear to be less frequent.
  3. In vitro Studies without Translational Relevance:
    There seems to be a decrease in in vitro studies that do not connect findings to potential clinical applications or translational research.
  4. Animal Models with Limited Human Relevance:
    Research utilizing animal models that do not effectively mimic human disease conditions is becoming less common, as the field emphasizes more relevant translational models.

Similar Journals

Cell Discovery

Pioneering Discoveries in Molecular and Genetic Sciences
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

BMC Molecular and Cell Biology

Championing high-quality insights in molecular and cell biology.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Genes & Diseases

Shedding light on the genetic foundations of disease.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

TRENDS IN CELL BIOLOGY

Uncovering the Latest Trends in Cell Science
Publisher: CELL PRESSISSN: 0962-8924Frequency: 12 issues/year

TRENDS IN CELL BIOLOGY, published by CELL PRESS, is a premier journal in the field of cell biology, recognized for its high-impact contributions since its inception in 1991. As a distinguished member of the Q1 quartile within its category, the journal holds an impressive Scopus ranking of #8 out of 285, placing it in the 97th percentile of the field, which underscores its reputation for excellence. The journal serves as an essential resource for researchers, professionals, and students who are engaged with groundbreaking advancements in biochemistry, genetics, and molecular biology. Although it is not open access, it provides critical insights into the latest trends, reviews, and advancements in cell biology, making it a crucial tool for anyone committed to understanding the complexities of cellular systems. With a focus on innovative and transformative research, TRENDS IN CELL BIOLOGY continues to shape the discourse in cell biology and enhance the scientific community's knowledge.

Cell Reports

Fostering Collaboration for a Healthier Tomorrow
Publisher: CELL PRESSISSN: 2211-1247Frequency: 48 issues/year

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.

DNA AND CELL BIOLOGY

Exploring the Frontiers of Molecular Discovery
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

Protein & Cell

Pioneering Discoveries in Protein Functions and Cellular Processes
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

GENES TO CELLS

Exploring the Interplay of Genetics and Cell Biology
Publisher: WILEYISSN: 1356-9597Frequency: 12 issues/year

GENES TO CELLS is a distinguished peer-reviewed journal published by Wiley, offering valuable insights into the intricate world of cell biology and genetics. With an ISSN of 1356-9597 and an E-ISSN of 1365-2443, this journal has been contributing to the academic community since its inception in 1996 and will continue its publishing journey until 2024. Recognized with a category quartile ranking of Q3 in both Cell Biology and Genetics, and Q2 in Medicine (Miscellaneous) as of 2023, it serves as an important platform for disseminating innovative research and reviews in molecular biology and related fields. Although it does not currently offer open access, the journal caters to a diverse readership by providing comprehensive studies that are essential for professionals, researchers, and students aiming to deepen their understanding of genetic mechanisms and cellular functions. Situated in the United Kingdom, GENES TO CELLS continues to play a pivotal role in shaping the future of biological research.

CELL PROLIFERATION

Empowering Global Collaboration in Cell Biology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

DEVELOPMENTAL CELL

Pioneering Research in Cell and Developmental Biology
Publisher: CELL PRESSISSN: 1534-5807Frequency: 12 issues/year

DEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.